Literature DB >> 25356819

Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement.

Peter Mazzone1, Charles A Powell2, Douglas Arenberg3, Peter Bach4, Frank Detterbeck5, Michael K Gould6, Michael T Jaklitsch7, James Jett8, David Naidich9, Anil Vachani10, Renda Soylemez Wiener11, Gerard Silvestri12.   

Abstract

Lung cancer screening with a low-dose chest CT scan can result in more benefit than harm when performed in settings committed to developing and maintaining high-quality programs. This project aimed to identify the components of screening that should be a part of all lung cancer screening programs. To do so, committees with expertise in lung cancer screening were assembled by the Thoracic Oncology Network of the American College of Chest Physicians (CHEST) and the Thoracic Oncology Assembly of the American Thoracic Society (ATS). Lung cancer program components were derived from evidence-based reviews of lung cancer screening and supplemented by expert opinion. This statement was developed and modified based on iterative feedback of the committees. Nine essential components of a lung cancer screening program were identified. Within these components 21 Policy Statements were developed and translated into criteria that could be used to assess the qualification of a program as a screening facility. Two additional Policy Statements related to the need for multisociety governance of lung cancer screening were developed. High-quality lung cancer screening programs can be developed within the presented framework of nine essential program components outlined by our committees. The statement was developed, reviewed, and formally approved by the leadership of CHEST and the ATS. It was subsequently endorsed by the American Association of Throacic Surgery, American Cancer Society, and the American Society of Preventive Oncology.

Entities:  

Mesh:

Year:  2015        PMID: 25356819      PMCID: PMC4502754          DOI: 10.1378/chest.14-2500

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  27 in total

1.  Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society.

Authors:  Heber MacMahon; John H M Austin; Gordon Gamsu; Christian J Herold; James R Jett; David P Naidich; Edward F Patz; Stephen J Swensen
Journal:  Radiology       Date:  2005-11       Impact factor: 11.105

2.  Results of the two incidence screenings in the National Lung Screening Trial.

Authors:  Denise R Aberle; Sarah DeMello; Christine D Berg; William C Black; Brenda Brewer; Timothy R Church; Kathy L Clingan; Fenghai Duan; Richard M Fagerstrom; Ilana F Gareen; Constantine A Gatsonis; David S Gierada; Amanda Jain; Gordon C Jones; Irene Mahon; Pamela M Marcus; Joshua M Rathmell; JoRean Sicks
Journal:  N Engl J Med       Date:  2013-09-05       Impact factor: 91.245

3.  What the heck is a "nodule"? A qualitative study of veterans with pulmonary nodules.

Authors:  Christopher G Slatore; Nancy Press; David H Au; J Randall Curtis; Renda Soylemez Wiener; Linda Ganzini
Journal:  Ann Am Thorac Soc       Date:  2013-08

4.  Selection criteria for lung-cancer screening.

Authors:  Martin C Tammemägi; Hormuzd A Katki; William G Hocking; Timothy R Church; Neil Caporaso; Paul A Kvale; Anil K Chaturvedi; Gerard A Silvestri; Tom L Riley; John Commins; Christine D Berg
Journal:  N Engl J Med       Date:  2013-02-21       Impact factor: 91.245

5.  Four-year results of low-dose CT screening and nodule management in the ITALUNG trial.

Authors:  Andrea Lopes Pegna; Giulia Picozzi; Fabio Falaschi; Laura Carrozzi; Massimo Falchini; Francesca Maria Carozzi; Francesco Pistelli; Camilla Comin; Annalisa Deliperi; Michela Grazzini; Florio Innocenti; Cristina Maddau; Alessandra Vella; Luca Vaggelli; Eugenio Paci; Mario Mascalchi
Journal:  J Thorac Oncol       Date:  2013-07       Impact factor: 15.609

6.  Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial.

Authors:  Nanda Horeweg; Carlijn M van der Aalst; Erik Thunnissen; Kristiaan Nackaerts; Carla Weenink; Harry J M Groen; Jan-Willem J Lammers; Joachim G Aerts; Ernst T Scholten; Joost van Rosmalen; Willem Mali; Matthijs Oudkerk; Harry J de Koning
Journal:  Am J Respir Crit Care Med       Date:  2013-04-15       Impact factor: 21.405

7.  Targeting of low-dose CT screening according to the risk of lung-cancer death.

Authors:  Anil K Chaturvedi; Hormuzd A Katki; Stephanie A Kovalchik; Martin Tammemagi; Christine D Berg; Neil E Caporaso; Tom L Riley; Mary Korch; Gerard A Silvestri
Journal:  N Engl J Med       Date:  2013-07-18       Impact factor: 91.245

8.  Results of initial low-dose computed tomographic screening for lung cancer.

Authors:  Timothy R Church; William C Black; Denise R Aberle; Christine D Berg; Kathy L Clingan; Fenghai Duan; Richard M Fagerstrom; Ilana F Gareen; David S Gierada; Gordon C Jones; Irene Mahon; Pamela M Marcus; JoRean D Sicks; Amanda Jain; Sarah Baum
Journal:  N Engl J Med       Date:  2013-05-23       Impact factor: 91.245

Review 9.  Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Michael K Gould; Jessica Donington; William R Lynch; Peter J Mazzone; David E Midthun; David P Naidich; Renda Soylemez Wiener
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

Review 10.  Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  Frank C Detterbeck; Peter J Mazzone; David P Naidich; Peter B Bach
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

View more
  71 in total

1.  An Official American Thoracic Society Research Statement: A Research Framework for Pulmonary Nodule Evaluation and Management.

Authors:  Christopher G Slatore; Nanda Horeweg; James R Jett; David E Midthun; Charles A Powell; Renda Soylemez Wiener; Juan P Wisnivesky; Michael K Gould
Journal:  Am J Respir Crit Care Med       Date:  2015-08-15       Impact factor: 21.405

2.  Association of Cigarette Type and Nicotine Dependence in Patients Presenting for Lung Cancer Screening.

Authors:  Nichole T Tanner; Nina A Thomas; Ralph Ward; Alana Rojewski; Mulugeta Gebregziabher; Benjamin A Toll; Gerard A Silvestri
Journal:  Chest       Date:  2020-06-27       Impact factor: 9.410

3.  Tobacco Dependence Predicts Higher Lung Cancer and Mortality Rates and Lower Rates of Smoking Cessation in the National Lung Screening Trial.

Authors:  Alana M Rojewski; Nichole T Tanner; Lin Dai; James G Ravenel; Mulugeta Gebregziabher; Gerard A Silvestri; Benjamin A Toll
Journal:  Chest       Date:  2018-05-21       Impact factor: 9.410

4.  Incidental Findings in a Decentralized Lung Cancer Screening Program.

Authors:  Katherine Janssen; Kelsey Schertz; Nathan Rubin; Abbie Begnaud
Journal:  Ann Am Thorac Soc       Date:  2019-09

5.  Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in Europe.

Authors:  Jesper Holst Pedersen; Witold Rzyman; Giulia Veronesi; Thomas A D'Amico; Paul Van Schil; Laureano Molins; Gilbert Massard; Gaetano Rocco
Journal:  Eur J Cardiothorac Surg       Date:  2017-03-01       Impact factor: 4.191

6.  Pros: After stereotactic ablative radiotherapy for a peripheral early-stage non-small cell lung cancer, radiological suspicion of a local recurrence can be sufficient indication to proceed to salvage therapy.

Authors:  Timothy K Nguyen; David A Palma
Journal:  Transl Lung Cancer Res       Date:  2016-12

7.  Multidisciplinary quality improvement initiative to standardize reporting of lung cancer screening.

Authors:  Laura Cubillos; Alison T Brenner; Katherine Birchard; Louise M Henderson; Paul L Molina; Michael Pignone; Shana Ratner; M Patricia Rivera; Laura Jones; Daniel S Reuland
Journal:  Transl Lung Cancer Res       Date:  2018-09

8.  Quality of Cancer Surveillance Clinical Practice Guidelines: Specificity and Consistency of Recommendations.

Authors:  Ryan P Merkow; Deborah Korenstein; Rubaya Yeahia; Peter B Bach; Shrujal S Baxi
Journal:  JAMA Intern Med       Date:  2017-05-01       Impact factor: 21.873

9.  Reduced Expiratory Flow Rate among Heavy Smokers Increases Lung Cancer Risk. Results from the National Lung Screening Trial-American College of Radiology Imaging Network Cohort.

Authors:  Raewyn J Hopkins; Fenghai Duan; Caroline Chiles; Erin M Greco; Greg D Gamble; Denise Aberle; Robert P Young
Journal:  Ann Am Thorac Soc       Date:  2017-03

10.  Readiness for Implementation of Lung Cancer Screening. A National Survey of Veterans Affairs Pulmonologists.

Authors:  Melissa H Tukey; Jack A Clark; Rendelle Bolton; Michael J Kelley; Christopher G Slatore; David H Au; Renda Soylemez Wiener
Journal:  Ann Am Thorac Soc       Date:  2016-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.